Literature DB >> 1556359

Cognitive function in non-demented older adults with hypothyroidism.

D Osterweil1, K Syndulko, S N Cohen, P D Pettler-Jennings, J M Hershman, J L Cummings, W W Tourtellotte, D H Solomon.   

Abstract

PURPOSE: (1) to evaluate objectively changes in cognitive function and electrophysiologic characteristics associated with hypothyroidism of varying severity and duration in primarily older persons; (2) to determine whether these changes are reversible when a euthyroid state has been attained after treatment with thyroid hormone. SUBJECTS AND METHODS: We enrolled 54 non-demented hypothyroid patients (31-99, mean 68.6 +/- 16.4 years) with biochemical evidence of hypothyroidism (38 had overt and 14 had minimal hypothyroidism) and 30 euthyroid controls (31-96, mean 63.7 +/- 18.4 years) screened for good general health. We evaluated attention, orientation, memory, learning, visual-spatial abilities, calculation, language, visual scanning, and motor speed using standardized neuropsychological tests. Electrophysiological measures of neurocognitive function included the P300 latency component of the auditory Event-Related Potentials (ERP) and conduction speed from eye to cortex, the P100 latency component of the Patterned Visual-Evoked Potential (PVEP). All patients were studied when hypothyroid. A subset of patients with minimal initial test abnormalities were available to be retested when euthyroid, 5 and 9 months after onset of thyroid replacement therapy.
RESULTS: Hypothyroid patients showed significantly lower scores on the Mini-Mental Status Test (MMS) and on five of 14 neuropsychological tests as compared to controls. The neuropsychological tests affected were copying a cube (visual-spatial function), the Inglis Paired Associates Learning Test-Low and Medium association items (memory and learning), Animal Naming (word fluency/production), and the Trail Making A test (attention, visual scanning and psychomotor function. Hypothyroidism also was associated with longer P100 latencies of PVEPs to 20' checks, but showed no significant differences in PVEP P100 latency to 50' checks, nor in the latency of the auditory ERP component P300. There was a statistically significant correlation between a laboratory index of the severity of hypothyroidism (serum T4) and the Inglis Medium Association items and Animal Naming. There was a statistically significant improvement after 5 months of treatment on three of the timed performance tests that previous studies have shown to be most sensitive to brain dysfunction.
CONCLUSION: Hypothyroidism in non-demented older adults is associated with impairments in learning, word fluency, visual-spatial abilities, and some aspect of attention, visual scanning, and motor speed. The MMS by itself was sensitive in differentiating hypothyroid patients with cognitive deficits from controls, while electrophysiological measures did not generally differentiate the hypothyroid patients from normal controls. The MMS was not sensitive to treatment effects, but treatment was associated with significant improvements in three of the most sensitive measures of cognitive dysfunction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556359     DOI: 10.1111/j.1532-5415.1992.tb02130.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  50 in total

Review 1.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Alone in the home.

Authors:  Roy Yaari; Geri R Hall; Helle Brand; James D Seward; Anna D Burke; Adam S Fleisher; Jan Dougherty; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2012-02-23

3.  Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Authors:  John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas
Journal:  J Am Med Dir Assoc       Date:  2015-09-01       Impact factor: 4.669

4.  Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial.

Authors:  M A Pollock; A Sturrock; K Marshall; K M Davidson; C J Kelly; A D McMahon; E H McLaren
Journal:  BMJ       Date:  2001-10-20

5.  Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives.

Authors:  Samuel C Byrne; Pamela Miller; Samarys Seguinot-Medina; Vi Waghiyi; C Loren Buck; Frank A von Hippel; David O Carpenter
Journal:  Environ Res       Date:  2018-06-27       Impact factor: 6.498

6.  Thyroid stimulating hormone and cognition during severe, transient hypothyroidism.

Authors:  Frank V Schraml; Pamela W Goslar; Leslie Baxter; Lori L Beason-Held
Journal:  Neuro Endocrinol Lett       Date:  2011       Impact factor: 0.765

7.  Thyroid hormones and cognitive functioning in healthy, euthyroid women: a correlational study.

Authors:  Miglena Grigorova; Barbara B Sherwin
Journal:  Horm Behav       Date:  2012-02-20       Impact factor: 3.587

Review 8.  Psychiatric and cognitive manifestations of hypothyroidism.

Authors:  Mary H Samuels
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

9.  Thyroid hormones are associated with longitudinal cognitive change in an urban adult population.

Authors:  May A Beydoun; Hind A Beydoun; Ola S Rostant; Greg A Dore; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2015-08-08       Impact factor: 4.673

10.  Thyroid Function and Cognition during Aging.

Authors:  M E Bégin; M F Langlois; D Lorrain; S C Cunnane
Journal:  Curr Gerontol Geriatr Res       Date:  2008-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.